References
- Rossouw JE, Anderson GL, Prentice RL, et al., Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principles results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–33
- De Villiers TJ, Pines A, Panay N, et al., on behalf of the International Menopause Society. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013;16:316–37
- Santen RJ, Allred DC, Ardoin SP, et al., Endocrine society: executive summary. Postmenopausal hormone therapy: an endocrine society scientific statement. J Clin Endocrinol Metab 2010;95:S1–66
- Pines A. Postmenopausal hormone therapy: the way ahead. Maturitas 2007;57:3–5
- Nelson H. Commonly used types of postmenopausal estrogen for treatment of hot flashes. JAMA 2004;291:1610–20
- Simon JA, Snabes MC. Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen. Exp Opin Investig Drugs 2007;16:2005–20
- Crandall C. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety. J Women's Health (Larchmt) 2003;12:723–47
- Renoux C, Dell'aniello S, Garbe E, Suissa S. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case control study. BMJ 2010;340:c2519
- Utian WH, Archer DF, Bachmann GA, et al., North American Menopause Society. Position statement. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause 2008;15:584–603
- Sierra B, Hidalgo LA, Chedraui PA. Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale. Maturitas 2005;51:236–45
- Meinert C. Clinical trials: design, conduct and analysis. New York: Oxford University Press; 1986
- Altman D, Schulz K, Moher D, et al., CONSORT GROUP (Consolidated Standards of Reporting Trials). The Revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663–94
- García AE, Cárdenas ML, Sandoval MD, Mayorga AH. Hiperplasia endometrial: análisis de serie de casos diagnosticados en biopsia endometrial. Rev Chil Obstet Ginecol 2010;75:146–52
- L'Hermite M, Simoncini T, Fuller S, Genazzani AR. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review. Maturitas 2008;60:185–201
- Ettinger B. Rationale for use of lower estrogen doses for postmenopausal hormone therapy. Maturitas 2007;57:81–4
- Carranza LS. Dosis bajas de terapia hormonal durante el climaterio. Ginecol Obstet Mex 2008;76:267–74
- Velazco MV. Estrógenos a dosis bajas en el climaterio. Rev Med Inst Mex Seguro Soc 2007;45:381–7
- Trabal JF, Lenihan Jr JP, Melchione TE, et al. Low-dose unopposed estrogens: preliminary findings on the frequency and duration of vaginal bleeding in postmenopausal women receiving esterified estrogens over a two-year period. Menopause 1997;4:130–8
- Utian WH, Burry KA, Archer DF, et al. Efficacy and safety of low, standard, and high treatments of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. The Esclim Study Group. Am J Obstet Gynecol 1999;181:71–9
- Paoletti R, Wenger N. Review of the International Position Paper on Women's Health and Menopause. A comprehensive approach. Circulation 2003;107:1336–9
- Lobo RA, Davis SR, De Villiers TJ, et al. Prevention of diseases after menopause. Climacteric 2014;17:540–56
- Blümel JE, Chedraui P, Baron G, et al., Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Menopausal symptoms appear before the menopause and persist 5 years beyond: a detailed analysis of a multinational study. Climacteric 2012;15:542–51
- Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;60:10–18
- Committee for Proprietary Medicinal Products (CPMP). 1997. Points to consider on hormone replacement therapy. Available from: http://www.emea.eu.int/pdfs/human/ewp/002197en.pdf [last accessed Oct 2014]